Crossmark

Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1–34) analogs in women

Published Online: 2026-01-03

Authors

Lu, Ko-Hsiu https://orcid.org/0000-0001-7600-4268
Wang, Shiow-Ing

Yang, Shun-Fa
Funding

Funding for this research was provided by:

Chung Shan Medical University Hospital (CSH-2024-D-003)
License Information

Text and Data Mining valid from 2026-01-03

Version of Record valid from 2026-02-03
More Information

Article History

Received: 29 October 2025

Accepted: 23 December 2025

First Online: 3 January 2026

Declarations

:

: This study was approved by the Institutional Review Board of Chung Shan Medical University Hospital (approval no. CS2-23208) and was reported in accordance with the RECORD (Reporting of Studies Conducted Using Observational Routinely Collected Health Data) guidelines.

: Not Applicable.

: The authors declare no competing interests.

Document is current